{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:46:58Z","timestamp":1792457218917,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010463","name":"Institut Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lungcan.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:41:53Z","timestamp":1639100513000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Surgical or medical strategy for locally-advanced, stage IIIA\/B-N2 non-small cell lung cancer: Reproducibility of decision-making at a multidisciplinary tumor board"],"prefix":"10.1016","volume":"163","author":[{"given":"Juliette","family":"Mainguene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Basse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Beaucaire-Danel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Brian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina","family":"Grigoroiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Gossot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Luporsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Caliandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Seguin-Givelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2021.12.004_b0005","first-page":"8","article-title":"Global Epidemiology of Lung Cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann. GlobHealth"},{"key":"10.1016\/j.lungcan.2021.12.004_b0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2021.12.004_b0015","doi-asserted-by":"crossref","unstructured":"D.S. Ettinger, D.E. Wood, D.L. Aisner, W. Akerley, J.R. Bauman, A. Bharat, et al., NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021, J. Natl. Compr. Canc. Netw. 19 (2021) 254\u201366. DOI: 10.6004\/jnccn.2021.0013.","DOI":"10.6004\/jnccn.2021.0013"},{"issue":"3","key":"10.1016\/j.lungcan.2021.12.004_b0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejcts.2009.04.013","article-title":"Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival","volume":"36","author":"Decaluw\u00e9","year":"2009","journal-title":"Eur. J. Cardio-Thoracic Surg."},{"issue":"2","key":"10.1016\/j.lungcan.2021.12.004_b0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12149-015-1038-7","article-title":"FDG PET\/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy","volume":"30","author":"Kremer","year":"2016","journal-title":"Ann. Nucl. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2021.12.004_b0030","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2214\/AJR.19.21258","article-title":"Sleeve Lobectomy for Non-Small Cell Lung Cancers: Predictive CT Features for Resectability and Outcome Analysis","volume":"213","author":"Lee","year":"2019","journal-title":"Am. J. Roentgenol."},{"issue":"16","key":"10.1016\/j.lungcan.2021.12.004_b0035","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.2000.18.16.2981","article-title":"Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications","volume":"18","author":"Andre","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2021.12.004_b0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jtcvs.2010.02.018","article-title":"Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients","volume":"140","author":"Stefani","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"9687","key":"10.1016\/j.lungcan.2021.12.004_b0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.lungcan.2021.12.004_b0050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/djk093","article-title":"Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer","volume":"99","author":"van Meerbeeck","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"24","key":"10.1016\/j.lungcan.2021.12.004_b0055","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10308","key":"10.1016\/j.lungcan.2021.12.004_b0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB\u2013IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2021.12.004_b0065","doi-asserted-by":"crossref","unstructured":"J. Spicer, C. Wang, F. Tanaka, et al., Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC), J. Clin. Oncol. 3915_suppl (2021) 8503-8503. DOI: 10.1200\/JCO.2021.39.15_suppl.8503 Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021) 8503-8503.","DOI":"10.1200\/JCO.2021.39.15_suppl.8503"},{"key":"10.1016\/j.lungcan.2021.12.004_b0070","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in Respected EGFR-Mutated Non-Small-Cell Lung Cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2021.12.004_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-06809-1","article-title":"Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome","volume":"20","author":"Freytag","year":"2020","journal-title":"BMC Cancer."},{"issue":"4","key":"10.1016\/j.lungcan.2021.12.004_b0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2018.01.006","article-title":"Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach","volume":"19","author":"Bilfinger","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.lungcan.2021.12.004_b0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ctrv.2015.11.007","article-title":"The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature","volume":"42","author":"Pillay","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2021.12.004_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-020-4930-3","article-title":"The impact of tumor board on cancer care: evidence from an umbrella review","volume":"20","author":"Specchia","year":"2020","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.lungcan.2021.12.004_b0095","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"ESMO Guidelines Committee. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2021.12.004_b0100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","article-title":"Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer","volume":"45","author":"De Leyn","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2021.12.004_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.00184308","article-title":"ERS\/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)","volume":"34","author":"Brunelli","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.lungcan.2021.12.004_b0110","first-page":"507","article-title":"Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board. Transl Lung","volume":"9","author":"Kim","year":"2020","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lungcan.2021.12.004_b0115","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.21873\/invivo.12568","article-title":"Surgical Outcomes in Patients With Centrally Located Non-small Cell Lung Cancer","volume":"35","author":"Tsukioka","year":"2021","journal-title":"In Vivo"},{"key":"10.1016\/j.lungcan.2021.12.004_b0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jtcvs.2010.02.018","article-title":"Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients","volume":"140","author":"Stefani","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"7","key":"10.1016\/j.lungcan.2021.12.004_b0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jso.20644","article-title":"Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol 8935","volume":"94","author":"Jaklitsch","year":"2006","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2021.12.004_b0130","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.ijrobp.2009.01.069","article-title":"Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer","volume":"75","author":"Higgins","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.lungcan.2021.12.004_b0135","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jtcvs.2015.09.127","article-title":"Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer","volume":"151","author":"Ripley","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2021.12.004_b0140","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bjc.6602825","article-title":"An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer","volume":"93","author":"Forrest","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2021.12.004_b0145","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1445-5994.2009.02019.x","article-title":"The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer","volume":"39","author":"Bydder","year":"2009","journal-title":"Int Med J."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221006322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221006322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T23:45:59Z","timestamp":1717544759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500221006322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"alternative-id":["S0169500221006322"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.12.004","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical or medical strategy for locally-advanced, stage IIIA\/B-N2 non-small cell lung cancer: Reproducibility of decision-making at a multidisciplinary tumor board","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}